Low-dose naltrexone for treatment of duodenal Crohn’s disease in a pediatric patient (Abstract)

Low-dose naltrexone for treatment of duodenal Crohn’s disease in a pediatric patient Inflamm Bowel Dis September 2010 https://academic.oup.com/ibdjournal/article/16/9/1457/4628412 Naltrexone is an opioid receptor antagonist used as an opiate antidote. It acts as a competitive antagonist at several opioid receptor sites, showing the highest affinity for mu receptors. Studies have shown that opioids have immunomodulatory activity, […]

Low-dose naltrexone therapy improves active Crohn’s disease (Abstract)

Low-dose naltrexone therapy improves active Crohn’s disease Am J Gastroenterol April 2007 https://pubmed.ncbi.nlm.nih.gov/17222320/ Objectives: Endogenous opioids and opioid antagonists have been shown to play a role in healing and repair of tissues. In an open-labeled pilot prospective trial, the safety and efficacy of low-dose naltrexone (LDN), an opioid antagonist, were tested in patients with active […]

Psychoneuroimmunological approach to gastrointestinal related pain IAbstract)

Psychoneuroimmunological approach to gastrointestinal related pain Scand J Pain October 2017 https://pubmed.ncbi.nlm.nih.gov/29122501/ Background and purpose (aims): Psychoneuroimmunology is both a theoretical and practical field of medicine in which human biology and psychology are considered an interconnected unity. Through such a framework it is possible to elucidate complex syndromes in gastrointestinal related pain, particularly chronic non-malignant. […]

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients (Abstract)

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients J Transl Med 09 March 2018 https://pubmed.ncbi.nlm.nih.gov/29523156/ Background: Around 30% of patients with inflammatory bowel disease (IBD) are refractory to current IBD drugs or relapse over time. Novel treatments are called for, and low dose Naltrexone (LDN) may provide a safe, easily accessible […]

Low dose naltrexone for induction of remission in Crohn’s disease (Abstract)

Low dose naltrexone for induction of remission in Crohn’s disease Cochrane Database Syst Rev 01 April 2018 https://pubmed.ncbi.nlm.nih.gov/29607497/ Background: Crohn’s disease is a transmural, relapsing inflammatory condition afflicting the digestive tract. Opioid signalling, long known to affect secretion and motility in the gut, has been implicated in the inflammatory cascade of Crohn’s disease. Low dose […]

The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease… (Abstract)

The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental Before-and-After Prescription Database Study Erratum: Corrigendum: The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental Before-and-After Prescription Database Study. J Crohns Colitis 10 December 2019 https://pubmed.ncbi.nlm.nih.gov/31499520/ Background and aims: Low-dose naltrexone [LDN] is a controversial off-label […]

Corrigendum: The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease… (Abstract)

Corrigendum: The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental Before-and-After Prescription Database Study  J Crohns Colitis 09 September 2019 https://academic.oup.com/ecco-jcc/advance-article/doi/10.1093/ecco-jcc/jjz101/5566443 There were some errors in Table 3, Supplementary data 3 and Supplementary data 5 in the original article. These have now been corrected in the online version. The method […]

Use of low dose naltrexone and change in use of prescription drugs in patients with inflammatory bowel disease… (Abstract)

Use of low dose naltrexone and change in use of prescription drugs in patients with inflammatory bowel disease – A drug utilization cohort study based on the Norwegian prescription register Research in Social and Administrative Pharmacy May–June 2017 https://www.sciencedirect.com/science/article/abs/pii/S1551741117302152 LDN is used increasingly for multiple autoimmune diseases including inflammatory bowel diseases. This study looked a […]

Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders (Abstract)

Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders Int J Pharm Compd Mar-Apr 2010 https://mail.google.com/mail/u/0?ui=2&ik=b5d7923c33&attid=0.2&permmsgid=msg-f:1668161843235939361&th=1726805badf06421&view=att&disp=safe Use of low dose naltrexone has been advocated for a variety of medical problems. Only a few articles published in peer review journals have documented side effects of low dose naltrexone. The purpose of this study was to […]

Low Dose Naltrexone Reduces In Vitro Endoplasmic Reticulum Stress and Stimulates Wound Healing in Intestinal Epithelial Cells (Abstract)

Low Dose Naltrexone Reduces In Vitro Endoplasmic Reticulum Stress and Stimulates Wound Healing in Intestinal Epithelial Cells Journal of Crohn’s and Colitis March 2016 https://academic.oup.com/ecco-jcc/article/10/suppl_1/S136/2481649 Naltrexone (NTX), a μ-opioid receptor (MOR) antagonist, up regulates MOR and its ligands when used at low doses. It may have a beneficial effect in the treatment of IBD by […]